Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
81.05
-1.94 (-2.34%)
At close: Feb 22, 2026
Market Cap13.68B +99.8%
Revenue (ttm)9.30B +32.8%
Net Income1.26B +8.1%
EPS7.45 -4.7%
Shares Out168.76M
PE Ratio10.88
Forward PE10.68
Dividend1.50 (1.85%)
Ex-Dividend DateApr 22, 2025
Volume145,193
Average Volume466,657
Open82.99
Previous Close82.99
Day's Range81.00 - 84.95
52-Week Range43.60 - 87.12
Beta0.63
RSI51.94
Earnings DateMar 2, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements